GLP-1 (7-37) Insulinotropin cas 106612-94-6

Insulinotropin, also known as GLP-1 (7-37) and Tglp-1, is a potent stimulator of insulin secretion at concentrations as low as 5 X 10(-11) M (3- to 10-fold increases over basal). GLP-I(1-37) had no effect on insulin secretion even at concentrations as high as 5 X 10(-7) M. The earlier demonstration of specific liberation of GLP-I(7-37) in the intestine and pancreas, and the magnitude of the insulinotropic effect at such low concentrations, suggest that GLP-I(7-37) participates in the physiological regulation of insulin secretion.

Related Products:

Plecanatide; Linaclotide; Carbetocin; Octreotide acetate; Terlipressin; Cetrorelix; Desmopressin; Desmopressin acetate; Degarelix; Goserelin acetate; Ganirelix Acetate; Abarelix; Semaglutide

[1]. Sarrauste de Menthiere, C. et al. Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production. European journal of medicinal chemistry 39, 473-480, doi:10.1016/j.ejmech.2004.02.002 (2004).

[2]. Hargrove DM, et al. Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short- or long-term administration. Metabolism. 1995 Sep;44(9):1231-7.